Last reviewed · How we verify
NCT03791242
Ketogenic Diet and CPAP Previous Bariatric Surgery
NA trial testing Cpap and ketogenic diet in Obstructed Sleep Apnea Syndrome in Patient Candidate to Baratric Surgery in 66 participants. Completed in 19 May 2021.
19 March 2021
Quick facts
| Lead sponsor | University of Roma La Sapienza |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 66 |
| Start date | 21 March 2019 |
| Primary completion | 19 March 2021 |
| Estimated completion | 19 May 2021 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Cpap and ketogenic diet
Conditions studied
- Obstructed Sleep Apnea Syndrome in Patient Candidate to Baratric Surgery — all drugs for Obstructed Sleep Apnea Syndrome in Patient Candidate to Baratric Surgery →
Sponsor
University of Roma La Sapienza
Who can join
Adults 18 to 65, any sex, with Obstructed Sleep Apnea Syndrome in Patient Candidate to Baratric Surgery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Obstructive Sleep Apnea Syndrome (OSAS) and obesity tend to coexist and are often associated with arterial hypertension, dyslipidaemia, and insulin resistance \[1\]. Polysomnography (PSG) is the standard technique for diagnosing OSAS and determining its severity \[2\]. The results of the examination provide the Apnea-Hypopnea Index \[AHI\], or the Respiratory Disturbance Index \[RDI\]), which will be used to quantify apnea and classify its severity based on an international score. In general, an AHI scoring less than 5 is considered "normal" (5-15 mild sleep apnea; \>15 moderate sleep apnea; ≥30 severe sleep apnea). In order to improve those parameters in obese patients who have been diagnosed with OSAS and are candidates for BS (BS), national and international guidelines recommend preoperative CPAP (Continuous Positive Airway Pressure) treatment in order to reduce anaesthesia risks \[3-6\]. Furthermore, several studies report that obese OSAS patients benefit from preoperative weight loss \[1,7\] (in terms of AHI index, night snoring and arterial hypertension). Obese patients who are candidates for BS often go on a preoperative diet in order to decrease weight and liver volume (especially of the left lobe) and correct any vitamin/mineral deficiency. The results of a recently published study show that 4 weeks of Ketogenic Micronutrient Enriched Diet (KMED) significantly reduce body weight, liver lobe volume and vitamin/mineral deficiencies in obese patients who prepare to undergo BS \[8\], with resulting foreseeable reduction of intraoperative complications and surgical time. To date, there are no prospective multicenter randomized trials demonstrating whether a preoperative ketogenic diet associated with CPAP use improves OSAS versus treatment with CPAP alone, with the possibility of reducing the preoperative treatment period. Aim of the study: To assess the clinical advantage in combining two preoperative strategies (CPAP + KMED) compared to preoperative treatment with CPAP alone, for the reduction of surgical risks in morbidly obese patients with severe OSAS who are scheduled for BS.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Low-Calorie Ketogenic Diet with Continuous Positive Airway Pressure to Alleviate Severe Obstructive Sleep Apnea Syndrome in Patients with Obesity Scheduled for Bariatric/Metabolic Surgery: a Pilot, Prospective, Randomized Multicenter Comparative Study.
Schiavo L, Pierro R, Asteria C, Calabrese P, et al · · 2022 · cited 34× · PMID 34802065 · DOI 10.1007/s11695-021-05811-1
Verify or expand the search:
- PubMed search for NCT03791242
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Roma La Sapienza trials
Trials by the same sponsor.
- NCT07485023 — Oral Versus Intravenous Iron for Anemia Diagnosed After 34 Weeks of Gestation · NA · not yet recruiting
- NCT07305519 — The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin · NA · not yet recruiting
- NCT07520968 — ABX Versus CHX in NSPT: a RCT · NA · active not recruiting
- NCT07109596 — Integration of Clinical, Biological and Psycho-social Variables for a Gender-sensitive Frailty Prediction · recruiting
- NCT07490574 — Trial of Underwater Versus Gas-Insufflation Colorectal Endoscopic Submucosal DisseEtion · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03791242 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Roma La Sapienza
- Last refreshed: 25 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03791242.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing